Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 29, 2015 6:56 AM ET

Healthcare Equipment and Supplies

Company Overview of ConforMIS, Inc.

Company Overview

ConforMIS, Inc., a medical technology company, develops, manufactures, and sells customized joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iUni G2, a unicompartmental product for treatment of the medial or lateral compartment of the knee; and iDuo G2, a bicompartmental partial implant for patients with osteoarthritis of the patellofemoral compartment of the knee and either the medial or lateral compartment of the knee, as well as provides iJigs, customized single-use patient-specific instruments. It is also developing iTotal Hip, a customized...

28 Crosby Drive

Bedford, MA 01730

United States

Founded in 2004

342 Employees

Phone:

781-345-9001

Fax:

781-345-0147

Key Executives for ConforMIS, Inc.

Founder, Chief Executive Officer, President, Director and Chairman of Asia Strategy Committee
Age: 52
Total Annual Compensation: $365.0K
Chief Financial Officer
Age: 51
Total Annual Compensation: $231.9K
Chief Technology Officer
Age: 46
Total Annual Compensation: $230.1K
Compensation as of Fiscal Year 2014.

ConforMIS, Inc. Key Developments

ConforMIS, Inc.(NasdaqGS:CFMS) added to NASDAQ Composite Index

ConforMIS, Inc. has been added to Nasdaq Composite Index.

ConforMIS, Inc. Announces Restated Certificate of Incorporation

On July 7, 2015, ConforMIS, Inc. filed a restated certificate of incorporation with the Secretary of State of the State of Delaware in connection with the closing of the initial public offering of shares of the Company's common stock. The company's board of directors and stockholders previously approved the restated certificate to be filed in connection with, and to be effective upon, the closing of the IPO. The restated certificate amends and restates in its entirety the Company's certificate of incorporation to, among other things: authorize 200,000,000 shares of common stock; eliminate all references to the previously existing series of preferred stock; authorize 5,000,000 shares of undesignated preferred stock that may be issued from time to time by the company's board of directors in one or more series; establish a classified board of directors, divided into three classes with staggered three-year terms, with one class of directors to be elected at each annual meeting of the company's stockholders; provide that the authorized number of directors may be changed only by the resolution of the company's board of directors, subject to the rights of any holders of any then outstanding series of preferred stock; provide that directors may be removed from office only for cause and only upon the affirmative vote of the holders of at least 75% of the votes that all of the company's stockholders would be entitled to cast in an election of directors; provide that any vacancy on the company's board of directors, including a vacancy resulting from an enlargement of the board of directors, may be filled only by vote of a majority of the directors then in office, subject to the rights of any holders of any then outstanding series of preferred stock; and eliminate the ability of the Company's stockholders to take action by written consent in lieu of a meeting and call special meetings of stockholders.

ConforMIS Might Seek Acquisitions

ConforMIS, Inc. has filed an IPO in the amount of $172.50 million. Although ConforMIS has no current agreements, commitments or understandings for any specific acquisitions or in-licenses at this time, it may use a portion of the net proceeds for these purposes.

Similar Private Companies By Industry

Company Name Region
Vital Motion Inc. United States
Neural Signals, Inc. United States
Medical Modeling Inc. United States
Scientia Vascular, LLC United States
The Brewer Company United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ConforMIS, Inc., please visit www.conformis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.